DPHARMA

1.210

DUOPHARMA BIOTECH BERHAD

Date of change	01 Sep 2026
Name	ENCIK SHAHIN FAROUQUE BIN JAMMAL AHMAD
Age	52
Gender	Male
Nationality	Malaysia
Designation	Chairman
Directorate	Non Independent and Non Executive
Type of change	Appointment

Major/Field of Study

Institute/University

Additional Information

Degree

Bachelor of Science (Accounting & Finance)

London School of Economics and Political Science, University of London

Others

International Baccalaureate (IB)

United World College of South East Asia (UWCSEA), Singapore

Working experience and occupation	Encik Shahin Farouque Bin Jammal Ahmad is currently the Deputy Group Chief Investment Officer, Private & Strategic Investment of Permodalan Nasional Berhad (PNB). He has over 20 years of experience in investment, corporate restructuring and strategy. Prior to joining PNB, he was the Executive Director of the Investments Division of Khazanah Nasional Berhad, where he was involved in various investments and served on the boards of several companies within Khazanah Nasional Berhad portfolio. Prior to joining Khazanah Nasional Berhad in 2016, he held various positions with commercial and investment banks in Malaysia and the region. He currently serves as PNB nominee on the Board of Axiata Group Berhad and Ekuiti Nasional Berhad.
Directorships in public companies and listed issuers (if any)	(1) Axiata Group Berhad (2) Ekuiti Nasional Berhad
Family relationship with any director and/or major shareholder of the listed issuer	None
Any conflict of interests that he/she has with the listed issuer	None
Details of any interest in the securities of the listed issuer or its subsidiaries	None

Remarks :

Encik Shahin Farouque Bin Jammal Ahmad is also a nominee of PNB on the Board of Duopharma Biotech Berhad.